Weight regain risk is highest in the first 3 to 6 months after stopping, with some patients reporting 30-50% of lost weight returning during this window
First review your administration technique and dose the 3 mg dose is not therapeutic then arrange a comprehensive diabetes review including HbA1c measurement and consideration of medication intensification
Are there any risks or side effects people commonly report
Read more in our detailed guide on AOD 9604 and how this HGH fragment works to reduce visceral fat without suppressing appetite
Key details Compounded semaglutide and tirzepatide in injection and microdose injection formats, plus the branded options Wegovy, Ozempic, Mounjaro, and Zepbound
Your healthcare provider customizes a treatment tailored to your health goals, assesses any necessary lab work, and identifies gaps in your weight management plan